Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies.

Name: Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies.
Author: Miller, Kathleen L

Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies. — المؤلف: Miller, Kathleen L — Expert opinion on orphan drugs Mar 2022

المؤلف: Miller, Kathleen L
النشر: Expert opinion on orphan drugs Mar 2022
الوصف: 265-272 p.